Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Ahmad Moolla

BSc (Hons), MBBS (Hons) MEd MRCP

Novo Nordisk Clinical Research Training Fellow & DPhil Student

I am a Specialist Registrar and Clinical Research Fellow in Diabetes, Endocrinology and Metabolism. My undergraduate training was undertaken at Imperial College London from where I hold a BSc in Pharmacology and Toxicology and graduated in Clinical Medicine with Distinction. My postgraduate training includes the award of NIHR Academic Clinical Fellowships at Imperial College London and at Bart's and the London School of Medicine to pursue research in diabetes, obesity and metabolism, alongside my clinical practice. I also have considerable experience in medical education and clinical leadership. I hold a Masters in Education (MEd) and between 2010-11 I worked on secondment at the Department of Health  as a Clinical Advisor to the National Medical Director for the NHS in England where my portfolio included work on quality improvement and clinical leadership programmes within the NHS.    

My research is focused on non-alcoholic fatty liver disease (NAFLD), which is rapidly becoming the commonest cause of chronic liver disease worldwide and affects up to 70% of patients with Type 2 Diabetes Mellitus (T2DM). Based at the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) and the University of Oxford Centre for Clinical Magnetic Resonance (OCMR), I am investigating new treatments for NAFLD, including the utility of GLP-1 analogues as novel therapy, as well as investigating novel non-invasive techniques with which to stage and grade NAFLD and with which to assess treatment response.

Recent publications

More publications